Vitarka Therapeutics
3 known investors
Vitarka is a biotechnology company developing cancer therapeutics designed to deliver potent drugs to intracellular targets.
Investors · 3
Companies House · registry record
View on Companies House ↗- Registered name
- VITARKA THERAPEUTICS LTD
- Company number
- 13291464
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 25 Mar 2021
- Registered office
- Innovation House Innovation Way, Discovery Park, Sandwich, CT13 9FF
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 24 Mar 2026 · next due 7 Apr 2027
Current officers · 4
- John William Beadle — director, appointed 11 Nov 2024
- James Duncan Bruce Faulkner — director, appointed 11 Mar 2024
- Mayer Schreiber — director, appointed 5 Apr 2022
- Vineeta Tripathi — director, appointed 25 Mar 2021
Source: Companies House public register · retrieved 23 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Vitarka Therapeutics do?
- Vitarka is a biotechnology company developing cancer therapeutics designed to deliver potent drugs to intracellular targets.
- Who are Vitarka Therapeutics's investors?
- Vitarka Therapeutics's investors include Future Planet Capital, UK Innovation & Science Seed Fund, SOSV.